comparemela.com

Geneuro Innovation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GeNeuro Reports 2023 Full-Year Results and Provides Corporate Update

Phase 2 clinical trial of temelimab against neuropsychiatric syndromes of Post-COVID : Recruitment completed in November 2023; Topline results planned for end of June 2024. Cash position.

GeNeuro Reports 2023 Full-Year Results and Provides Corporate Update

GeNeuro Reports 2023 Full-Year Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

GeNeuro : Half yearly financial reports and audit reports/limited reviews / Half yearly financial report -October 06, 2023 at 11:14 am EDT

GeNeuro : 2022 Universal Registration Document

The EIB and GeNeuro Sign a EUR 25 Million Credit Line Backed by InvestEU to Support Clinical Developments Against Long-COVID

The EIB and GeNeuro Sign a EUR 25 Million Credit Line Backed by InvestEU to Support Clinical Developments Against Long-COVID
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.